VaxTRIALS, part of Emmes Group

Proud to be at the forefront of public health advancement! At VaxTRIALS, part of Emmes Group, our deep industry expertise and full-service global offering have empowered us to collaborate with a dedicated team of passionate professionals. Together, we've successfully delivered high-quality results on competitive timelines that have led to critical outcomes in the realm of vaccines. As we continue our journey, we remain committed to advancing public health and making a meaningful difference through our dedicated team. Together We Make It Possible! #PublicHealth #VaccineResearch #Teamwork #HealthcareInnovation #GlobalCRO

Meet Rodrigo Acevedo, our Regulatory Director, who exemplifies how great leadership directly impacts company success. His strategic insights and commitment to excellence in regulatory affairs drive innovation, compliance, and growth within VaxTRIALS, part of Emmes Group. #MeetOurLeaders #PassionDrivenClinicalResearch #Leadership #ClinicalTrials #RegulatoryAffairs

As the industry’s leading vaccine specialized CRO, VaxTRIALS, part of Emmes Group, is committed to building strong partnerships in vaccine research. With our philosophy of "Global Insight, Local Impact," we specialize in tailored solutions for vaccines and infectious disease trials, driven by passionate experts who consistently deliver proven results. Together with our partners, we're dedicated to navigating the future of clinical research and making a meaningful impact on global healthcare! Together We Make It Possible! #ClinicalTrials #VaccineResearch #InfectiousDiseases #GlobalHealth #CRO

Download our eBook: https://lnkd.in/eVGPmANQ for expert tips on navigating the complexities of regulatory and ethical approvals in vaccine trials. Leveraging our global footprint, local knowledge, and decades of clinical excellence, our eBook provides valuable strategies on expediting approvals, streamlining processes and more to help drive rapid and efficient trials. #VaccineTrials #ClinicalResearch #RegulatoryApprovals #CROpartner #ClinicalTrials

At VaxTRIALS, part of Emmes Group, we firmly believe in the crucial role that clinical research plays in developing new treatments and improving public health. Our partnership with ABRACRO reinforces our shared commitment to advancing healthcare through collaborative efforts, where members work together to optimize best practices and streamline processes in clinical research.  Together We Make It Possible! #ABRACRO #TogetherWeMakeItPossible #VaxTRIALS #ClinicalTrialsStudies #Partnership

Engaging key study personnel early is crucial for aligning on study goals and ensuring efficient communication. VaxTRIALS’ proactive approach to feasibility exercises coupled with our tech-enabled solutions allows for rapid enrollment and seamless coordination, ensuring trials are quicker, flexible, and more cost-effective. Discover more strategies for streamlining your vaccine trials in our latest eBook: https://lnkd.in/etM3NhhM #VaccineTrials #ClinicalTrials #TrialEnrollement #StudyStartUp #CROpartner #ClinicalResearch

Embracing Our Values at VaxTRIALS, part of Emmes Group! 🌟 At VaxTRIALS, part of Emmes Group, we cherish the balance of physical, emotional, social, and financial well-being in our daily lives. Our adaptable and open-minded approach allows us to navigate change with honesty, courage, and responsibility. Join us in embodying the values that make us Vax – transparent communication, respectful interactions, and proactive problem-solving. Together, we make it possible. #VaxValues #BuildingTogether"

Exciting News! After our successful support of ILiAD Biotechnologies, LLC Phase II IB-201P BPZE1 study, we were chosen to conduct the upcoming Phase III studies of their lead pertussis vaccine candidate, BPZE! Read more: https://lnkd.in/eJzEKCeR

Success Factor #1 in our eBook, "How to Shorten Start-Up Timelines in Vaccine Trials," emphasizes the importance of relying on in-country staff. Local teams bring invaluable knowledge of healthcare systems, regulatory environments, and cultural nuances, ensuring that trials run smoothly and efficiently. Their on-the-ground insights can help mitigate potential delays and enhance trial outcomes. Discover all six critical success factors by downloading our eBook: https://lnkd.in/enz_m-5t #ClinicalTrials #VaccineResearch #HealthcareInnovation #VaxTRIALS #EmmesGroup

The spread of diseases carried by mosquitoes (vector-borne diseases) changes yearly and across the globe. Dengue fever is a growing concern in Latin America and the Caribbean, with Brazil being hit the hardest (83% of cases). Paraguay (5.3%) and Argentina (3.7%) also see significant cases, contributing to 92% of cases and 87% of deaths in the region. Facing dengue is the task of all sectors of society. At VaxTRIALS, part of EmmesGroup, we join the awareness campaign about this public health problem. Together we make it possible! #VBD #Dengue #WHO #denguefever #stopdengue #fightdengue #health #publichealth